Editor's Note: August featured some fascinating stories, including multiple recalls for the same heart devices and the annual ranking of the top U.S. hospitals for cardiology. We also learned more about a new-look TAVR valve designed to save the heart team valuable time. Another big topic in August was AI's potential to reshape echocardiography; this is certainly an area we're watching closely in the months ahead as imaging companies prepare for RSNA. As always, thank you for reading along with us each morning. We appreciate it. - Michael Walter | Editor Editor's Note: August featured some fascinating stories, including multiple recalls for the same heart devices and the annual ranking of the top U.S. hospitals for cardiology. We also learned more about a new-look TAVR valve designed to save the heart team valuable time. Another big topic in August was AI's potential to reshape echocardiography; this is certainly an area we're watching closely in the months ahead as imaging companies prepare for RSNA.
As always, thank you for reading along with us each morning. We appreciate it. - Michael Walter | Editor |
|
The latest Class I recall is due to mechanical issues that can cause the devices to stop charging their batteries. The latest Class I recall is due to mechanical issues that can cause the devices to stop charging their batteries. | | |
|
U.S. News & World Report's annual rankings of heart hospitals named Cleveland Clinic No. 1, once again, but there were many changes among the other top 25 hospitals. U.S. News & World Report's annual rankings of heart hospitals named Cleveland Clinic No. 1, once again, but there were many changes among the other top 25 hospitals. | | |
|
This latest recall was brought on by electrical failures and includes more than 4,500 devices. There have been 26 complaints due to the issue but no reported injuries or deaths. This latest recall was brought on by electrical failures and includes more than 4,500 devices. There have been 26 complaints due to the issue but no reported injuries or deaths. | | |
|
The new-look system is able to evaluate a situation and anticipate what users may need next. The new-look system is able to evaluate a situation and anticipate what users may need next. | | |
|
“This situation unacceptably exacerbates the interventional cardiology workforce shortage and threatens to directly impact the care of patients," SCAI wrote in a new statement. “This situation unacceptably exacerbates the interventional cardiology workforce shortage and threatens to directly impact the care of patients," SCAI wrote in a new statement. | | |
|
A majority of the proceeds raised would go toward "general corporate purposes," which could mean anything from research and development to investments in other healthcare companies. A majority of the proceeds raised would go toward "general corporate purposes," which could mean anything from research and development to investments in other healthcare companies. | | |
|
The new valve arrives fully premounted on a delivery system and was designed to allow resheathing or complete recapture/redeployment if necessary. The new valve arrives fully premounted on a delivery system and was designed to allow resheathing or complete recapture/redeployment if necessary. | | |
|
Partho Sengupta, MD, an expert on the use of AI in cardiology, says some of the technologies being developed today will fundamentally change how cardiologists and sonographers do their jobs. Partho Sengupta, MD, an expert on the use of AI in cardiology, says some of the technologies being developed today will fundamentally change how cardiologists and sonographers do their jobs. | | |
|
Rebecca Hahn, MD, examines the growing role of the dedicated interventional echocardiographer and how these imagers are paid. Rebecca Hahn, MD, examines the growing role of the dedicated interventional echocardiographer and how these imagers are paid. | | |
|
Researchers have recently determined that the medication, originally developed to treat diabetes, can contribute to weight loss and reduce a patient's MACE risk by up to 20%. Researchers have recently determined that the medication, originally developed to treat diabetes, can contribute to weight loss and reduce a patient's MACE risk by up to 20%. | | |
|
